{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-050777","form_type":"8-K","ticker":"GLSI","cik":"0001799788","company_name":"Greenwich LifeSciences, Inc.","filed_at":"2024-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.674370+00:00","generated_at":"2026-05-29T01:44:50.109095+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Greenwich LifeSciences holds 2024 annual meeting; all director nominees elected, equity plan amendment approved","bullets":["All five director nominees elected with majority support; no votes against, only abstentions and broker non-votes.","Ratification of RBSM as independent auditor for FY2024 approved: 9,224,694 for, 10,077 against, 2,644 abstain.","Amendment to 2019 Equity Incentive Plan to increase reserved shares from 1.5M to 4.0M approved: 8,067,672 for, 164,730 against.","Total shares represented at meeting: 12,848,165, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-050777","json":"https://secwatch.observer/filing/0001493152-24-050777.json","markdown":"https://secwatch.observer/filing/0001493152-24-050777.md","text":"https://secwatch.observer/filing/0001493152-24-050777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799788/000149315224050777/0001493152-24-050777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799788/000149315224050777/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:44:50.109095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}